Hong Kong (HKSAR) – The Department of Health (DH) today (March 4) ordered a licensed drug company, GlaxoSmithKline Ltd. (GSK), to recall from the market 144 units of three of its vaccines because of suspected quality defect. The products to be recalled are 115 units of Fluarix vaccine (Registration No.: HK-43003; Batch No.: AFLUA510AB) from […]
First African country introduces GSK's pneumococcal vaccine
GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan national immunisation programme. Kenya is the first African country to receive pneumococcal vaccines through the innovative financing mechanism known as the Advance Market Commitment (AMC), which is designed to bring heavily discounted vaccines to children living in the world’s poorest countries. At a […]
GSK, Binnopharm aim for Russia’s vaccine market
By: Tracy Staton 29 November 2010 GlaxoSmithKline has teamed up with another emerging markets partner. The drugmaker inked a deal with Russian vaccine firm JSC Binnopharm to make and sell several of its big vaccines in that country. It’s just the latest in a series of tie-ups in developing countries for GSK, which is pinning […]
